| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 25 | ₹5,850 |
| HNI / NII | 35 | 875 | ₹2,04,750 |
| bHNI / bNII | 171 | 4,275 | ₹10,00,350 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 25,00,000 (50.00%) | — | ₹6,000.00 Cr |
| NII / HNI (Total) | — | 7,50,000 (15.00%) | — | ₹1,800.00 Cr |
| Retail Investors | — | 17,50,000 (35.00%) | — | ₹4,200.00 Cr |
| Total ** | — | 50,00,000 (100.00%) | — | ₹120,000.00 Cr |
| Metric | 31-Jan-11 | 31-Mar-10 | 31-Mar-09 |
|---|---|---|---|
| Revenue | 29257.61 | 16935.66 | 9115.59 |
| PAT | 3105.12 | 1507.78 | 510.75 |
| EBITDA | — | — | — |
| Net Worth | — | — | — |
| Total Assets | — | — | — |
| Reserves | — | — | — |
| Borrowings | — | — | — |
Incorporated in 2006, Aanjaneya Lifecare Ltd a leading research based integrated pharmaceutical company with established research, manufacturing & marketing capabilities. Company’s product portfolio includes Bulk Drugs, Finished Dosage Forms, Herbal Medicines, Inhalers, Lozenges and Animal Health.
Aanjaneya has a manufacturing facility in Mahad near Mumbai. This facility provides multi-therapeutic product offerings comprising high-end Alkaloids, Quinine Salts, and Veterinary APIs & Cytotoxic API's.
Company also has a Finished Dosages Facility at Perungut Pune. This facility is for manufacturing various types of dosage forms such as Liquid Syrups, oral tablets, lozenges and Gels in several product categories complying with international standards.
Aanjaneya‘s manufacturing facilities are ISO 9001-2000 and WHO GMP certified. As on March 31st 2010 Aanjaneya had 222 employees.